Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Principal Investigator
Name
Ming Liu
Degrees
M.D.
Institution
Beijing Hospital
Position Title
Head of department
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-606
Initial CDAS Request Approval
Apr 16, 2020
Title
Prostate-specific antigen screening rates and factors associated with screening in American men
Summary
The prostate-specific antigen (PSA) test is used in America to detect prostate cancer (PCa) despite mixed recommendations.Complications arising from false-positives are common, posing as a cancer-screening concern. Our work aim to estimates some American rates of PSA screening and identifies men at increased odds for PSA screening.
Aims

The purpose of this study was to investigate factors associated with prostate cancer screening behaviors among men over 50 in America.

Collaborators

Shengjing Liu Xiyuan Hospital of China Academy of Chinese Medical Sciences